Местное лечение раневой инфекции: что нового за последнее десятилетие? | КМАХ

Местное лечение раневой инфекции: что нового за последнее десятилетие?

Клиническая микробиология и антимикробная химиотерапия. 2026; 28(1):13-24

​ Андреев В.А., Привольнев В.В., Родин А.В., Новиков И.А., Голуб А.В.
10.36488/cmac.2026.1.13-24
раны раневые инфекции местная терапия антимикробная терапия
Раздел
Болезни и возбудители
Тип
Обзор
Публикация
Клиническая микробиология и антимикробная химиотерапия. 2026; 28(1):13-24

Аннотация

Местное лечение раневых инфекций остается предпочтительным способом терапии, снижающим риск нежелательных системных лекарственных реакций при обеспечении высоких терапевтических концентраций в тканях раны. Настоящая статья представляет собой анализ клинических исследований местной терапии острых и хронических ран за последнее десятилетие с комментариями о ценности этих данных с точки зрения реальной клинической практики, рекомендациями практикующим специалистам по лечению ран, предположениями о направлениях поиска путей борьбы с раневыми инфекциями. Здесь не обсуждаются более известные рутинные практики, полностью или частично сохраняющие свою актуальность с конца прошлого века, также не рассматриваются средства, ускоряющие регенерацию и эпителизацию в ране.

Владислав Андреевич Андреев

ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России, Смоленск, Россия

Привольнев Владислав Владимирович

ООО «МВС-МЕД», Москва, Россия

Родин А.В.

ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России, Смоленск, Россия

Новиков И.А.

ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России, Смоленск, Россия

Голуб Алексей Викторович

ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России, Смоленск, Россия

  • 1. Puca V., Marulli R.Z., Grande R., Vitale I., Niro A., Molinaro G., et al. Microbial species isolated from infected wounds and antimicrobial resistance analysis: data emerging from a three-years retrospective study. Antibiotics. 2021;10(10):1162. DOI: 10.3390/antibiotics10101162
  • 2. Bowler P.G. Wound pathophysiology, infection and therapeutic options. Ann Med. 2002;34(6):419-427. DOI: 10.1080/078538902321012360
  • 3. Raziyeva K., Kim Y., Zharkinbekov Z., Kassymbek K., Jimi S., Saparov A. Immunology of acute and chronic wound healing. Biomolecules. 2021;11(5):700. DOI: 10.3390/biom11050700
  • 4. Golub A.V., Privolnev V.V. Topical antibacterial therapy for surgical skin and soft tissue infections in outpatient settings: summands of success. Rany i ranevye infekcii. Zhurnal imeni prof. B.M. Kostyuchyonka. 2014;1(1):33-38. Russian. (Голуб А.В., Привольнев В.В. Местная антибактериальная терапия хирургических инфекций кожи и мягких тканей в амбулаторных условиях: слагаемые успеха. Раны и раневые инфекции. Журнал имени проф. Б.М. Костючёнка. 2014;1(1):33-38.)
  • 5. Li S., Renick P., Senkowsky J., Nair A., Tang L. Diagnostics for wound infections. Adv Wound Care (New Rochelle). 2021;10(6):317-327. DOI: 10.1089/wound.2019.1103
  • 6. Sen C.K., Roy S., Mathew-Steiner S.S., Gordillo G.M. Biofilm management in wound care. Plast Reconstr Surg. 2021;148(2):275e-288e. DOI: 10.1097/PRS.0000000000008142
  • 7. Golub A.V. Bacterial biofilms – a new target for therapy? Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2012;14:23-29. Russian. (Голуб А.В. Бактериальные биопленки – новая цель терапии? Клиническая микробиология и антимикробная химиотерапия. 2012;14: 23-29.)
  • 8. Roy R., Tiwari M., Donelli G., Tiwari V. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9(1):522-554. DOI: 10.1080/21505594.2017.1313372
  • 9. Kalan L., Loesche M., Hodkinson B.P., Heilmann K., Ruthel G., Gardner S.E., et al. Redefining the chronicwound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. mBio. 2016;7(5):e01058-16. DOI: 10.1128/mBio.01058-16
  • 10. Thomas D.C., Tsu C.L., Nain R.A., Arsat N., Fun S.S., Sahid Nik Lah N.A. The role of debridement in wound bed preparation in chronic wound: a narrative review. Ann Med Surg. 2021;71:102876. DOI: 10.1016/j.amsu.2021.102876
  • 11. Privolnev V.V., Paskhalova Yu.S., Rodin A.V., Mitish V.A. Topical treatment of wounds and wound infection based on the results of anonymous questioning of Russian surgeons. Rany i Ranevye Infektsii. 2016;1:19-24. Russian. (Привольнев В.В., Пасхалова Ю.С., Родин А.В., Митиш В.А. Местное лечение ран и раневой инфекции по результатам анонимного анкетирования хирургов России. Раны и раневые инфекции. 2016;1:19-24.)
  • 12. Sibbald R.G., Elliott J.A., Persaud-Jaimangal R., GoodmanL., Armstrong D.G., Harley C., et al. Wound bed preparation 2021. Adv Skin Wound Care. 2021;34(4):183-195. DOI: 10.1097/01.ASW.0000733724.87630.d6
  • 13. Harries R.L., Bosanquet D.C., Harding K.G. Wound bed preparation: TIME for an update. Int Wound J. 2016;13(Suppl. 3):8-14. DOI: 10.1111/iwj.12662
  • 14. Privolnev V.V. Choice of an agent for the topical treatment of infected wounds. Rany i Ranevye Infektsii. 2015;2(1):13-18. Russian. (Привольнев В.В. Выбор препарата для местного лечения инфицированных ран. Раны и раневые инфекции. Журнал имени проф. Б.М. Костючёнка. 2015;2(1):13-18.)
  • 15. Al Saeed M. Prospective randomized comparison of controlled release ionic silver hydrophilic dressings and medicated honey-impregnated dressings in treating neuropathic diabetic foot ulcer. Saudi J Health Sci. 2019;8(1):25. DOI: 10.4103/sjhs.sjhs_111_18
  • 16. Tsang K.K., Kwong E.W., To T.S., Chung J.W., Wong T.K. A pilot randomized, controlled study of nanocrystalline silver, manuka honey, and conventional dressing in healing diabetic foot ulcer. Evid Based Complement Alternat Med. 2017;2017:5294890. DOI: 10.1155/2017/5294890
  • 17. Stryja J., Teplá K., Routek M., Pavlík V., Perutková D. Octenidine with hyaluronan dressing versus a silver dressing in hard-to-heal wounds: a post-marketing study. J Wound Care. 2023;32(8):480-491. DOI: 10.12968/jowc.2023.32.8.480
  • 18. Wei Y., Wu J., Chen Y., Fan K., Yu X., Li X., et al. PL-5 Investigators. Efficacy and safety of PL-5 (Peceleganan) spray for wound infections: a phase IIb randomized clinical trial. Ann Surg. 2023;277(1):43-49. DOI: 10.1097/SLA.0000000000005508
  • 19. Lu L.C., Chang F.Y., Lv G.Z., Lan S.H. Effectiveness and safety of compound polymyxin B ointment in treatment of burn wounds: a meta-analysis. J Burn Care Res. 2022;43(2):453-461. DOI: 10.1093/jbcr/irab099
  • 20. Miranda E., Bramono K., Yunir E., Reksodiputro M.H., Suwarsa O., Rengganis I., et al. Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trial. Arch Dermatol Res. 2023;315(9):2623-2633. DOI: 10.1007/s00403-023-02657-8
  • 21. Chan R.K., Nuutila K., Mathew-Steiner S.S., Diaz V., Anselmo K., Batchinsky M., et al. A prospective, randomized, controlled study to evaluate the effectiveness of a fabric-based wireless electroceutical dressing compared to standard-of-care treatment against acute trauma and burn wound biofilm infection. Adv Wound Care. 2024;13(1):1-13. DOI: 10.1089/wound.2023.0007
  • 22. Barki K.G., Das A., Dixith S., Ghatak P.D., MathewSteiner S., Schwab E., et al. Electric field based dressing disrupts mixed-species bacterial biofilm infection and restores functional wound healing. Ann Surg. 2019;269(4):756-766. DOI: 10.1097/SLA.0000000000002504
  • 23. Principi N., Silvestri E., Esposito S. Advantages and limitations of bacteriophages for the treatment of bacterial infections. Front Pharmacol. 2019;10:513. DOI: 10.3389/fphar.2019.00513
  • 24. Jault P., Leclerc T., Jennes S., Pirnay J.P., Que Y.A., Resch G., et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, doubleblind phase 1/2 trial. Lancet Infect Dis. 2019;19(1):35-45. DOI: 10.1016/S1473-3099(18)30482-1
  • 25. Vasina D.V., Antonova N.P., Grigoriev I.V., Yakimakha V.S., Lendel A.M., Nikiforova M.A., et al. Discovering the potentials of four phage endolysins to combat gramnegative infections. Front Microbiol. 2021;12:748718. DOI: 10.3389/fmicb.2021.748718
  • 26. Krasowski G., Jawień A., Tukiendorf A., Rybak Z., Junka A., Olejniczak-Nowakowska M., et al. A comparison of an antibacterial sandwich dressing vs dressing containing silver. Wound Repair Regen. 2015;23(4):525-530. DOI: 10.1111/wrr .12301
  • 27. Stryja J., Teplá K., Routek M., Pavlík V., Perutková D. Octenidine with hyaluronan dressing versus a silver dressing in hard-to-heal wounds: a post-marketing study. J Wound Care. 2023;32(8):480-491. DOI: 10.12968/jowc.2023.32.8.480
  • 28. Mo X., Cen J., Gibson E., Wang R., Percival S.L. An open multicenter comparative randomized clinical study on chitosan. Wound Repair Regen. 2015;23(4):518-524. DOI: 10.1111/wrr.12298
  • 29. Malone M., Radzieta M., Schwarzer S., Walker A., Bradley J., Jensen S.O. In vivo observations of biofilm adhering to a dialkylcarbamoyl chloride-coated mesh dressing when applied to diabetes-related foot ulcers: a proof-of-concept study. Int Wound J. 2023;20(6):1943-1953. DOI: 10.1111/iwj.14054
  • 30. Mosti G., Magliaro A., Mattaliano V., Picerni P., Angelotti N. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24(3):121-124. DOI: 10.12968/jowc.2015.24.3.121
  • 31. Borges E.L., Frison S.S., Honorato-Sampaio K., Guedes A.C.M., Lima V.L.A.N., Oliveira O.M.M., et al. Effect of polyhexamethylene biguanide solution on bacterial load and biofilm in venous leg ulcers: a randomized controlled trial. J Wound Ostomy Continence Nurs. 2018;45(5):425-431. DOI: 10.1097/W0N.0000000000000455
  • 32. Khan M., King E., Breisinger K., Serena L., Serena T.E. A double-blind trial comparing an antimicrobial combination to standard care in hard-to-heal wounds. J Wound Care. 2024;33(2):84-89. DOI: 10.12968/jowc.2024.33.2.84
  • 33. Serena T.E., Serena L., Al-Jalodi O., Patel K., Breisinger K. The efficacy of sodium hypochlorite antiseptic: a doubleblind, randomised controlled pilot study. J Wound Care. 2022;31(Suppl. 2):S32-S35. DOI: 10.12968/jowc.2022.31.Sup2.S32
  • 34. Krupka M., Bożek A., Bartusik-Aebisher D., Cieślar G., Kawczyk-Krupka A. Photodynamic therapy for the treatment of infected leg ulcers-a pilot study. Antibiotics. 2021;10(5):506. DOI: 10.3390/antibiotics10050506
  • 35. Lei X., Liu B., Huang Z., Wu J. A clinical study of photodynamic therapy for chronic skin ulcers in lower limbs infected with Pseudomonas aeruginosa. Arch Dermatol Res. 2015;307(1):49-55. DOI: 10.1007/s00403-014-1520-4
  • 36. Morley S., Griffiths J., Philips G., Moseley H., O'Grady C., Mellish K., et al. Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy. Br J Dermatol. 2013;168(3):617-624. DOI: 10 .1111/bjd.12098
  • 37. Mannucci E., Genovese S., Monami M., Navalesi G., Dotta F., Anichini R., et al. Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study – the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study. Acta Diabetol. 2014;51(3):435-440. DOI: 10.1007/ s00592-013-0533-3
  • 38. Miller K.G., Tran P.L., Haley C.L., Kruzek C., ColmerHamood J.A., Myntti M., et al. Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens. Antimicrob Agents Chemother. 2014;58(6):3060-3072. DOI: 10.1128/AAC.00108-14
  • 39. Gasca-Lozano L.E., Lucano-Landeros S., Ruiz-Mercado H., Salazar-Montes A., Sandoval-Rodríguez A., GarciaBañuelos J., et al. Pirfenidone accelerates wound healing in chronic diabetic foot ulcers: a randomized, double-blind controlled trial. J Diabetes Res. 2017:2017:3159798. DOI: 10.1155/ 2017/3159798
  • 40. Privolnev V., Rodin A., Fedorov R., Khvostov D. Prospects for the use of local antibiotic therapy in the treatment of osteomyelitis. Vrach. 2016;11:12-16. Russian. (Привольнев В., Родин А., Федоров Р., Хвостов Д. Перспективы использования местной антибиотикотерапии в лечении остеомиелита. Врач. 2016;11:12-16.)
  • 41. Chatterjee S., Sen S., Hazra A., Das A.K. Randomized controlled trial of topical mupirocin versus mupirocin with sucralfate combination in chronic skin ulcers. Indian J Pharmacol. 2019;51(5):316-322. DOI: 10.4103/ijp.IJP_237_17
  • 42. Raju R., Kethavath S.N., Sangavarapu S.M., Kanjarla P. Efficacy of cadexomer iodine in the treatment of chronic ulcers: a randomized, multicenter, controlled trial. Wounds. 2019;31(3):85-90. PMID: 30720444.
  • 43. Malone M., Schwarzer S., Radzieta M., Jeffries T., Walsh A., Dickson H.G., et al. Effect on total microbial load and community composition with two vs six-week topical Cadexomer Iodine for treating chronic biofilm infections in diabetic foot ulcers. Int Wound J. 2019;16(6):1477-1486. DOI: 10.1111/iwj.13219
  • 44. Lipsky B.A., Kim P.J., Murphy B., McKernan P.A., Armstrong D.G., Baker B.H.J. Topical pravibismane as adjunctive therapy for moderate or severe diabetic foot infections: a phase 1b randomized, multicenter, double-blind, placebo- controlled trial. Int Wound J. 2024;21(4):e14817. DOI: 10.1111/iwj.14817
  • 45. Buzzi M., de Freitas F., Winter M. A prospective, descriptive study to assess the clinical benefits of using Calendula officinalis hydroglycolic extract for the topical treatment of diabetic foot ulcers. Ostomy Wound Manage. 2016;62(3):8-24. PMID: 26978856.
  • 46. Strohal R., Dietrich S., Mittlböck M., Hämmerle G. Chronic wounds treated with cold atmospheric plasmajet versus best practice wound dressings: a multicenter, randomized, non-inferiority trial. Sci Rep. 2022;12(1):3645. DOI: 10.1038/s41598-022-07333
  • 47. Klebes M., Ulrich C., Kluschke F., Patzelt A., Vandersee S., Richter H., et al. Combined antibacterial effects of tissuetolerable plasma and a modern conventional liquid antiseptic on chronic wound treatment. J Biophotonics. 2015;8(5):382-391. DOI: 10.1002/jbio.201400007
  • 48. Amini M.R., Sheikh Hosseini M., Fatollah S., Mirpour S., Ghoranneviss M., Larijani B., et al. Beneficial effects of cold atmospheric plasma on inflammatory phase of diabetic foot ulcers; a randomized clinical trial. J Diabetes Metab Disord. 2020;19(2):895-905. DOI: 10.1007/s40200-020-00577-2
  • 49. Otaviano M.H., Salles M., Ching T.H., Dettoni J.L., Coulibaly I.G.S., Fukunaga E.T., et al. Topical Oxygen Jet Therapy (TOJT) for treating infected chronic surgical wounds. Braz J Infect Dis. 2021;25(2):101547. DOI: 10.1016/j.bjid.2021.101547
  • 50. Steadman W., Chapman P.R., Schuetz M., Schmutz B., Trampuz A., Tetsworth K. Local antibiotic delivery options in prosthetic joint infection. Antibiotics. 2023;12(4):752. DOI: 10.3390/antibiotics12040752
  • 51. Van Vugt T.A.G., Arts J.J., Geurts J.A.P. Antibiotic-loaded polymethylmethacrylate beads and spacers in treatment of orthopedic infections and the role of biofilm formation. Front Microbiol. 2019;10:1626. DOI: 10.3389/fmicb.2019.01626
  • 52. Henshaw F.R., Bolton T., Nube V., Hood A., Veldhoen D., Pfrunder L., et al. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study. J Diabetes Complications. 2014;28(6):850-857. DOI: 10.1016/j.jdiacomp.2014.07.012
  • 53. Aziz Z., Abdul Rasool Hassan B. The effects of honey compared to silver sulfadiazine for the treatment of burns: a systematic review of randomized controlled trials. Burns. 2017;43(1):50-57. DOI: 10.1016/j.burns.2016.07.004
  • 54. Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502. DOI: 10.1038/nrgastro.2017.75
  • 55. WGO Practice Guideline. Probiotics and prebiotics. World Gastroenterology Organization. 2023. Available at: www.worldgastroenterology.org/guidelines/probiotics-andprebiotics. Accessed August 28, 2025
  • 56. Bădăluță V.A., Curuțiu C., Dițu L.M., Holban A.M, Lazăr V. Probiotics in wound healing. Int J Mol Sci. 2024;25(11):5723. DOI: 10.3390/ijms25115723
  • 57. Ming Z., Han L., Bao M., Zhu H., Qiang S., Xue S., et al. Living bacterial hydrogels for accelerated infected wound healing. Adv Sci. 2021;8(24):e2102545. DOI: 10.1002/advs.202102545
  • 58. Stanbro J., Park J.M., Bond M., Stockelman M.G., Simons M.P., Watters C. Topical delivery of Lactobacillus culture supernatant increases survival and wound resolution in traumatic Acinetobacter baumannii infections. Probiotics Antimicrob Proteins. 2020;12(3):809-818. DOI: 10.1007/s12602-019-09603-z.
  • 59. Abootaleb M., Mohammadi Bandari N., Arbab Soleimani N. Interference of Lactobacillus casei with Pseudomonas aeruginosa in the treatment of infected burns in Wistar rats. Iran J Basic Med Sci. 2021;24(2):143-149. DOI: 10.22038/IJBMS.2020.47447.10920
  • 60. Argañaraz Aybar J.N., Ortiz Mayor S., Olea L., Garcia J.J., Nisoria S., Kolling Y., et al. Topical administration of Lactiplantibacillus plantarum accelerates the healing of chronic diabetic foot ulcers through modifications of infection, angiogenesis, macrophage phenotype and neutrophil response. Microorganisms. 2022;10(3):634. DOI: 10.3390/microorganisms10030634
Просмотров
0 Аннотация
0 PDF
0 Цитирования
Поделились